Diversity is richness: why data reporting according to sex, age, and ethnicity matters.

Heart Division, Royal Brompton and Harefield Hospitals and National Heart and Lung Institute, Imperial College, London SW3 6NP, UK; Center for Molecular Cardiology, University of Zurich, CH-8952 Schlieren-Zurich, Switzerland; Department of Physiology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA; Barbra Streisand Women’s Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA; Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; and Catholic University of the Sacred Heart, I-00168 Rome, Italy

[1]  G. Hindricks,et al.  European Society of Cardiology: Cardiovascular Disease Statistics 2019 (Executive Summary). , 2020, European heart journal. Quality of care & clinical outcomes.

[2]  E. V. van Beek,et al.  Sex associations and computed tomography coronary angiography-guided management in patients with stable chest pain , 2019, European heart journal.

[3]  A. Banerjee,et al.  Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006-2015. , 2019, European heart journal.

[4]  S. Bengs,et al.  Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome. , 2019, European heart journal.

[5]  K. Sliwa,et al.  Sex differences in heart failure. , 2019, European heart journal.

[6]  Teresa Y. Lin,et al.  Aggregation of Asian-American subgroups masks meaningful differences in health and health risks among Asian ethnicities: an electronic health record based cohort study , 2019, BMC Public Health.

[7]  James Zou,et al.  Sex and gender analysis improves science and engineering , 2019, Nature.

[8]  S. Gili,et al.  Comparison of the Effectiveness of Percutaneous Intervention of the Left-Main Coronary Artery With Everolimus-Eluting Stents in Women -Vs- Men. , 2019, The American journal of cardiology.

[9]  H. Kamel,et al.  Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14. , 2019, European heart journal.

[10]  A. Khera,et al.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary. , 2019, Circulation.

[11]  J. Coste,et al.  Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France , 2019, European heart journal.

[12]  Daniel E Forman,et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[13]  G. Parati,et al.  ACC/AHA Versus ESC/ESH on Hypertension Guidelines: JACC Guideline Comparison. , 2019, Journal of the American College of Cardiology.

[14]  S. Grundy,et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[15]  P. Noseworthy,et al.  Atrial fibrillation ablation in practice: assessing CABANA generalizability , 2019, European heart journal.

[16]  J. Saw,et al.  Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes , 2019, European heart journal.

[17]  A. Khera,et al.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[18]  N. Wenger,et al.  Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and Outcomes , 2019, Current cardiology reviews.

[19]  C. Mondo,et al.  Anthracycline induced cardiotoxicity in adult cancer patients: a prospective cohort study from a specialized oncology treatment centre in Uganda , 2019, African health sciences.

[20]  A. Roddick,et al.  Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis , 2019, JAMA.

[21]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension]. , 2019, Kardiologia polska.

[22]  A. Maas,et al.  European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection. , 2018, European heart journal.

[23]  C. Berry,et al.  Systemic microvascular dysfunction in microvascular and vasospastic angina , 2018, European heart journal.

[24]  G. Lip,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[25]  N. Cook,et al.  Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials , 2018, The Lancet.

[26]  Jeroen J. Bax,et al.  International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology , 2018, European heart journal.

[27]  Katrina Poppe,et al.  Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study , 2018, European heart journal.

[28]  C. N. Bairey Merz,et al.  Coronary microvascular dysfunction and heart failure with preserved ejection fraction as female-pattern cardiovascular disease: the chicken or the egg? , 2018, European heart journal.

[29]  P. Rothwell,et al.  Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study , 2017, The Lancet.

[30]  Emelia J. Benjamin,et al.  Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes , 2017, Circulation research.

[31]  Cora Lee Wetherington,et al.  Considering sex as a biological variable in preclinical research , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  J. Clayton,et al.  Reporting Sex, Gender, or Both in Clinical Research? , 2016, JAMA.

[33]  Ageing: Measuring our narrow strip of life , 2016, Nature.

[34]  Faisal Rahman,et al.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis , 2016, Nature Reviews Cardiology.

[35]  T. Babor,et al.  Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use , 2016, Research Integrity and Peer Review.

[36]  Doris A Taylor,et al.  Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists , 2016, Biology of Sex Differences.

[37]  J. Manson,et al.  Focused Cardiovascular Care for Women: The Need and Role in Clinical Practice. , 2016, Mayo Clinic proceedings.

[38]  K. Rexrode,et al.  Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association. , 2015, Circulation.

[39]  D. Atar,et al.  Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial. , 2015, European heart journal.

[40]  Jeroen J. Bax,et al.  Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. , 2015, The New England journal of medicine.

[41]  T. Lüscher,et al.  Gender disparities in acute coronary syndrome: a closing gap in the short-term outcome , 2015, Journal of cardiovascular medicine.

[42]  L. O. Schulz,et al.  High-Risk Populations: The Pimas of Arizona and Mexico , 2015, Current Obesity Reports.

[43]  Ambady Ramachandran,et al.  Diabetes in South-East Asia: an update. , 2014, Diabetes research and clinical practice.

[44]  H. Almodaimegh,et al.  Do women bleed more than men when prescribed novel oral anticoagulants for venous thromboembolism? A sex-based meta-analysis. , 2013, Thrombosis research.

[45]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[46]  B. Hemmelgarn,et al.  Outcomes After Acute Myocardial Infarction in South Asian, Chinese, and White Patients , 2010, Circulation.

[47]  R. Lampert.  Use of Antiarrhythmic Medications in Women , 2010 .

[48]  K. Alexander,et al.  Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial). , 2009, The American journal of cardiology.

[49]  V. Cuomo,et al.  Gender differences in drug responses. , 2007, Pharmacological research.

[50]  D. Singer,et al.  Age and the Risk of Warfarin‐Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation Study , 2006, Journal of the American Geriatrics Society.

[51]  M. Simoons,et al.  Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. , 2006, European heart journal.

[52]  J. Manson,et al.  A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women , 2005, The New England journal of medicine.

[53]  B. Kilshaw,et al.  The prevalence of diabetes mellitus in male Saudi Arabs , 1982, Diabetologia.

[54]  Werner Klein,et al.  Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) , 2003 .

[55]  B. Davis,et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.

[56]  V. Muller.  Exploring the biological contributions to human health: does sex matter? , 2001, Journal of women's health & gender-based medicine.

[57]  K. Grumbach,et al.  Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity. , 1999, American heart journal.